JOINN Laboratories Official Website Investor relations--information disclosure
中国·尊龙(z6mg·官方认证)网站-Official Platform
Home
About JOINN
Solutions
By Service Type
Research Animals & Models
Discovery Services
R&D and Production
Safety Assessment
Clinial Trials
Laboratory services
PV Services
By Molecule Type
Biologicals
Small molecule
Vaccine
Biosimilar
By Treatment Area
Tumor
Ophthalmic Diseases
Respiratory Disease
CNS Disease
Cardiovascular Disease
Metabolic Disease
Hematological Disease
inflammation
Infectious Diseases
By Industry
Pharmaceuticals
Feed and Veterinary Drugs
Medical Devices
New Chemicals and Pesticides
By Research Phase
drug screening
Production process
Non clinical research
clinical research
Quality Control
News & Events
Company News
Announcement
Media Coverage
Conference & Event
Investors
Information Disclosure
Corporate Governance
Stock Information
Investor Relations
Investor Interaction
CN
/
EN
Stock code
SSE: 603127
HKEX: 06127
Information Disclosure
JOINN adheres to the purpose of "Serve for Drug Innovation,
Focus on Safety Assessments and Monitoring of Drugs Throughout Life Cycles"
H shares
A shares
Prospectus Supplement
Performance Report
Notices
2025-04-29
2024 ANNUAL REPORT
download-PDF
2025-04-28
2025 FIRST QUARTERLY REPORT
download-PDF
2025-03-28
JOINN ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2024
download-PDF
2024-10-30
2024 THIRD QUARTERLY REPORT
download-PDF
2024-09-27
2024 Interim Report
download-PDF
<
1
2
3
4
5
6
>
